These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 9165025

  • 1. Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation.
    Tai H, Miyaura C, Pilbeam CC, Tamura T, Ohsugi Y, Koishihara Y, Kubodera N, Kawaguchi H, Raisz LG, Suda T.
    Endocrinology; 1997 Jun; 138(6):2372-9. PubMed ID: 9165025
    [Abstract] [Full Text] [Related]

  • 2. Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2.
    Koide M, Murase Y, Yamato K, Noguchi T, Okahashi N, Nishihara T.
    Biochem Biophys Res Commun; 1999 May 27; 259(1):97-102. PubMed ID: 10334922
    [Abstract] [Full Text] [Related]

  • 3. Involvement of cyclooxygenase-2 in interleukin-1alpha-induced prostaglandin production by human periodontal ligament cells.
    Noguchi K, Shitashige M, Ishikawa I.
    J Periodontol; 1999 Aug 27; 70(8):902-8. PubMed ID: 10476899
    [Abstract] [Full Text] [Related]

  • 4. Direct and indirect actions of fibroblast growth factor 2 on osteoclastic bone resorption in cultures.
    Kawaguchi H, Chikazu D, Nakamura K, Kumegawa M, Hakeda Y.
    J Bone Miner Res; 2000 Mar 27; 15(3):466-73. PubMed ID: 10750561
    [Abstract] [Full Text] [Related]

  • 5. Basic fibroblast growth factor induces osteoclast formation by reciprocally regulating the production of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in mouse osteoblastic cells.
    Nakagawa N, Yasuda H, Yano K, Mochizuki Si, Kobayashi N, Fujimoto H, Shima N, Morinaga T, Chikazu D, Kawaguchi H, Higashio K.
    Biochem Biophys Res Commun; 1999 Nov 27; 265(1):158-63. PubMed ID: 10548507
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-6 and its soluble receptor regulate the expression of insulin-like growth factor binding protein-5 in osteoblast cultures.
    Franchimont N, Durant D, Canalis E.
    Endocrinology; 1997 Aug 27; 138(8):3380-6. PubMed ID: 9231791
    [Abstract] [Full Text] [Related]

  • 7. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis.
    Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, Saito S, Inoue K, Kamatani N, Gillespie MT, Martin TJ, Suda T.
    J Clin Invest; 1999 May 27; 103(9):1345-52. PubMed ID: 10225978
    [Abstract] [Full Text] [Related]

  • 8. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts.
    Onoe Y, Miyaura C, Kaminakayashiki T, Nagai Y, Noguchi K, Chen QR, Seo H, Ohta H, Nozawa S, Kudo I, Suda T.
    J Immunol; 1996 Jan 15; 156(2):758-64. PubMed ID: 8543830
    [Abstract] [Full Text] [Related]

  • 9. Interaction between nitric oxide synthase and cyclooxygenase pathways in osteoblastic MC3T3-E1 cells.
    Kanematsu M, Ikeda K, Yamada Y.
    J Bone Miner Res; 1997 Nov 15; 12(11):1789-96. PubMed ID: 9383683
    [Abstract] [Full Text] [Related]

  • 10. Role of cyclo-oxygenase-2 induction in interleukin-1beta induced attenuation of cultured human airway smooth muscle cell cyclic AMP generation in response to isoprenaline.
    Pang L, Holland E, Knox AJ.
    Br J Pharmacol; 1998 Nov 15; 125(6):1320-8. PubMed ID: 9863663
    [Abstract] [Full Text] [Related]

  • 11. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors.
    Udagawa N, Takahashi N, Katagiri T, Tamura T, Wada S, Findlay DM, Martin TJ, Hirota H, Taga T, Kishimoto T, Suda T.
    J Exp Med; 1995 Nov 01; 182(5):1461-8. PubMed ID: 7595216
    [Abstract] [Full Text] [Related]

  • 12. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
    Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, Koishihara Y, Ohsugi Y, Kumaki K, Taga T.
    Proc Natl Acad Sci U S A; 1993 Dec 15; 90(24):11924-8. PubMed ID: 8265649
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-6 and soluble interleukin-6 receptor suppress osteoclastic differentiation by inducing PGE(2) production in chondrocytes.
    Honda K.
    J Oral Sci; 2011 Mar 15; 53(1):87-96. PubMed ID: 21467819
    [Abstract] [Full Text] [Related]

  • 14. Cyclooxygenase-2-dependent prostaglandin (PG) E2 downregulates matrix metalloproteinase-3 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells stimulated with interleukin-1alpha.
    Yan M, Noguchi K, Ruwanpura SM, Ishikawa I.
    J Periodontol; 2005 Jun 15; 76(6):929-35. PubMed ID: 15948687
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.
    Kotake S, Sato K, Kim KJ, Takahashi N, Udagawa N, Nakamura I, Yamaguchi A, Kishimoto T, Suda T, Kashiwazaki S.
    J Bone Miner Res; 1996 Jan 15; 11(1):88-95. PubMed ID: 8770701
    [Abstract] [Full Text] [Related]

  • 16. Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro.
    Lader CS, Flanagan AM.
    Endocrinology; 1998 Jul 15; 139(7):3157-64. PubMed ID: 9645689
    [Abstract] [Full Text] [Related]

  • 17. Induction of cyclooxygenase-2 by parathyroid hormone in human osteoblasts in culture.
    Maciel FM, Sarrazin P, Morisset S, Lora M, Patry C, Dumais R, de Brum-Fernandes AJ.
    J Rheumatol; 1997 Dec 15; 24(12):2429-35. PubMed ID: 9415654
    [Abstract] [Full Text] [Related]

  • 18. alpha-Lipoic acid inhibits inflammatory bone resorption by suppressing prostaglandin E2 synthesis.
    Ha H, Lee JH, Kim HN, Kim HM, Kwak HB, Lee S, Kim HH, Lee ZH.
    J Immunol; 2006 Jan 01; 176(1):111-7. PubMed ID: 16365401
    [Abstract] [Full Text] [Related]

  • 19. Regulation of the cellular expression of secretory and cytosolic phospholipases A2, and cyclooxygenase-2 by peptide growth factors.
    Pruzanski W, Stefanski E, Vadas P, Kennedy BP, van den Bosch H.
    Biochim Biophys Acta; 1998 May 27; 1403(1):47-56. PubMed ID: 9622592
    [Abstract] [Full Text] [Related]

  • 20. Involvement of prostaglandin endoperoxide H synthase-2 in osteoclast-like cell formation induced by interleukin-1 beta.
    Sato T, Morita I, Sakaguchi K, Nakahama KI, Smith WL, Dewitt DL, Murota SI.
    J Bone Miner Res; 1996 Mar 27; 11(3):392-400. PubMed ID: 8852950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.